{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T16:49:59Z","timestamp":1758991799553},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,12,23]],"date-time":"2009-12-23T00:00:00Z","timestamp":1261526400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm World Sci"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s11096-009-9354-4","type":"journal-article","created":{"date-parts":[[2009,12,22]],"date-time":"2009-12-22T07:25:41Z","timestamp":1261466741000},"page":"109-111","source":"Crossref","is-referenced-by-count":5,"title":["Severe ifosfamide-induced neurotoxicity: a case report"],"prefix":"10.1007","volume":"32","author":[{"given":"Sara","family":"Ramos Linares","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaqu\u00edn","family":"Bre\u00f1a Atienza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matilde","family":"Ch\u00e1fer Rudilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"R\u00edos Rull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Cabello Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Merino Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,23]]},"reference":[{"issue":"suppl 2","key":"9354_CR1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000073351","volume":"65","author":"J Klatersky","year":"2003","unstructured":"Klatersky J. Side effects of ifosfamide. Oncology. 2003;65(suppl 2):7\u201310.","journal-title":"Oncology"},{"key":"9354_CR2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00001813-200404000-00006","volume":"15","author":"C Rieger","year":"2004","unstructured":"Rieger C, Fiegl M, Tischer J, Ostermann H, Schiel X. Incidence and severity of ifosfamide-induced encephalopathy. Anti-Cancer Drugs. 2004;15:347\u201350.","journal-title":"Anti-Cancer Drugs"},{"issue":"2","key":"9354_CR3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.clon.2006.11.003","volume":"19","author":"T Ajithkumar","year":"2007","unstructured":"Ajithkumar T, Parkinson C, Shamshad F, Murray P. Ifosfamide encephalopathy. Clin Oncol. 2007;19(2):108\u201314.","journal-title":"Clin Oncol"},{"issue":"1","key":"9354_CR4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3324\/haematol.10661","volume":"92","author":"A Santoro","year":"2007","unstructured":"Santoro A, Magagnoli M, Spina M, Pinotti G, Siracusano L, Michieli M, et al. Ifosfamide, gemcitabine, vinorelbine: a new induction regimen for refractory, relapsed Hodgkin\u2019s lymphoma. Haematologica. 2007;92(1):35\u201341.","journal-title":"Haematologica"},{"key":"9354_CR5","unstructured":"Common Terminology Criteria for Adverse Events v3.0 (CTCAE). National Cancer Institute. Available: http:\/\/www.ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/ctcaev3.pdf . (Visit on April 2009)."},{"issue":"suppl 2","key":"9354_CR6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000073350","volume":"65","author":"M Furlanut","year":"2003","unstructured":"Furlanut M, Franceschi L. Pharmacology of Ifosfamide. Oncology. 2003;65(suppl 2):2\u20136.","journal-title":"Oncology"},{"key":"9354_CR7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1345\/aph.1G114","volume":"40","author":"PN Patel","year":"2006","unstructured":"Patel PN. Methylene blue for management of ifosfamide-induced encephalopathy. Ann Pharmacother. 2006;40:299\u2013303.","journal-title":"Ann Pharmacother"},{"issue":"3","key":"9354_CR8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.coc.0000158439.02724.5a","volume":"28","author":"KA David","year":"2005","unstructured":"David KA, Picus J. Evaluating risk factors for the development of ifosfamide encephalopathy. Am J Clin Oncol. 2005;28(3):277\u201380.","journal-title":"Am J Clin Oncol"},{"issue":"40","key":"9354_CR9","first-page":"299","volume":"2","author":"M Hamadani","year":"2006","unstructured":"Hamadani M, Awan F. Role of thiamine in managing ifosfamide-induced encephalopathy. J Oncol Pharm Pract. 2006;2(40):299\u2013303.","journal-title":"J Oncol Pharm Pract"},{"key":"9354_CR10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1054\/bjoc.1999.0917","volume":"82","author":"J Pelgrims","year":"2000","unstructured":"Pelgrims J, De Vos F, Van den Brande J, Schrijvers D, Prove A, Vermorken JB. Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature. Br J Cancer. 2000;82:291\u20134.","journal-title":"Br J Cancer"}],"container-title":["Pharmacy World & Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-009-9354-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-009-9354-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-009-9354-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T01:54:27Z","timestamp":1559354067000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-009-9354-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,23]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["9354"],"URL":"https:\/\/doi.org\/10.1007\/s11096-009-9354-4","relation":{},"ISSN":["0928-1231","1573-739X"],"issn-type":[{"value":"0928-1231","type":"print"},{"value":"1573-739X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,23]]}}}